In short. Exosome claims are worded to sound like categories while avoiding the obligations a category brings. Exosome-rich, conditioned media, growth factors, cosmeceutical and research use only each state no quantity, method or threshold, so none can be tested or disproved and none describes what is actually injected.
Key points
- A modifier with no unit cannot be measured, tested or disproved.
- Conditioned media is the liquid cells were grown in, not a purified preparation.
- Naming growth factors without naming which members or amounts makes no specific claim.
- Cosmeceutical has no standing as a regulatory category in most systems.
- A research-use-only label moves responsibility to whoever injects the product.
Why the vocabulary is not accidental
The vocabulary around these products is not accidental. Each term is chosen to describe something in a way that sounds like a category while avoiding the obligations a category brings. Reading the words as regulatory moves rather than as descriptions makes the whole field easier to follow.
Exosome-rich, a modifier with no unit
Rich is a modifier with no unit. It states no amount, no proportion and no method of measurement, and it cannot be disproved by testing because it asserts no number. A product can be described as exosome-rich and contain almost none, and nobody has said anything untrue in the ordinary sense.
Why a claim without a unit cannot be checked
Compare it with a statement of content, which names a measurement and can therefore be checked by someone who has the material. A claim that cannot be measured cannot be shown to be wrong, which is the point of choosing it. That is what makes such terms useful to a seller and useless to a reader.
Conditioned media
This is the liquid that cells were grown in. It contains whatever the cells released, plus everything that was in the medium to begin with: nutrients, salts, serum and additives. It is a complex mixture, not a purified preparation, and the phrase is accurate while implying a refinement that has not happened. A product described this way is closer to a dilute broth than to an isolated biological product.
Growth factors
Growth factors are a large family of signalling proteins with different effects, some of which promote repair and some of which drive cell division in ways that matter for the risk of uncontrolled growth. Naming the family without naming which members, in what amount and in what state, borrows the credibility of the general concept while making no specific claim. It also avoids the question of whether those proteins survive processing and storage at all.
Cosmeceutical, a category with no standing
This word has no standing as a regulatory category in most systems. It exists to place a product in the cosmetics conversation while allowing claims that cosmetics may not make. The gap it creates matters most here, because a product positioned as a cosmetic can be injected while being assessed as though it were a cream.
Research use only
Some products carry a statement that they are for laboratory use and not for human application. When such a product is then injected in a clinic, that label has done a specific job: it moved responsibility from the seller to whoever administered it, and it removed the product from the expectations that attach to something sold for people. The sentence is not a caution. It is a transfer of risk.
| Term | What it literally says | What it does not state | Why the wording helps a seller |
|---|---|---|---|
| Exosome-rich | A modifier with no unit | An amount, a proportion or a method | It cannot be tested or disproved |
| Conditioned media | The liquid cells were grown in | A purified preparation | It sounds refined while remaining a mixture |
| Growth factors | A family of signalling proteins | Which members, in what amount, in what state | It borrows credibility without a specific claim |
| Cosmeceutical | A cosmetics-adjacent description | A regulatory category | It allows claims cosmetics may not make |
| Research use only | For laboratory use, not human application | Any assessment for injection | It moves responsibility to whoever administers it |
| Cell-derived | An origin | A quantity, method or threshold | It states no measurable thing |
Which wordings shift responsibility?
The pattern is consistent across the terms. A description with no unit cannot be tested or disproved. A category that does not exist in regulation is used to make claims a real category would not allow. A laboratory-use label is placed on a product that is then injected into a person. In each case the wording moves an obligation away from the seller and towards the person receiving the product.
How should a reader treat these terms?
Treat each term as a question rather than a description. What amount does it state, by what method, against what threshold, and who could check it? Where the answer is nothing, nothing has been claimed that can be confirmed or contradicted, and the term should carry no weight in a decision.
Sources
- American Society of Plastic Surgeons: guidance on injectable products and the claims made for them
- National Institute for Health and Care Excellence: guidance on unlicensed injectable products
- Cochrane Library: systematic reviews on skin rejuvenation interventions
Source links open each organisation's search results for the topic. Document-level confirmation is pending the reviewer's sign-off.
Internal links
Frequently asked questions
What does exosome-rich actually measure?
Nothing. Rich is a modifier with no unit, so it states no amount, no proportion and no method of measurement, and it cannot be disproved by testing because it asserts no number. A product can be described that way and contain almost none, without anyone having said something untrue in the ordinary sense. A statement of content names a measurement and can be checked.
What is conditioned media?
The liquid that cells were grown in. It contains whatever the cells released, plus everything the medium contained to begin with: nutrients, salts, serum and additives. It is a complex mixture rather than a purified preparation, and the phrase is accurate while implying a refinement that has not taken place.
Is cosmeceutical a regulatory category?
In most systems it is not. It exists to place a product in the cosmetics conversation while allowing claims that cosmetics are not permitted to make. The gap it creates is the one that matters most here, because a product positioned as a cosmetic can be injected while being assessed as though it were a cream.
Risks & Limitations
- No product marketed as an exosome injectable has been through the approval process that would establish what it contains or what it does.
- Birth tissue derived material carries an infection risk when it is injected, and serious infections have been reported after such injections.
- The evidence behind most claims comes from laboratory work, animal models or uncontrolled case series, none of which establishes an effect in people.
- Regulatory status differs by country, and in most markets there is no approval for these products in any injectable use.
- Nothing on this site is a recommendation for or against any treatment, and it does not assess individual cases.
When to Seek Care
- Spreading redness, heat, swelling or discharge at an injection site: have it assessed promptly.
- Fever, or feeling unwell with a painful injected area: seek medical care without waiting.
- Severe or worsening pain, blistering, or skin breakdown where something was injected.
- Any new and persistent symptom after a treatment: have it assessed by a clinician who can examine you.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.